MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy

NCT03452345 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Medy-Tox